Antiviral drug resistance of herpes simplex virus;La resistance des virus herpes simplex aux antiviraux

Virologie

Volumn 3, Issue 1, 1999, Pages 57-63

  Morfin, F ^a   Thouvenot, D ^a   Najioullah, F ^a   Aymard, M ^a   Lina, B ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

Acylovir; Herpes simplex virus; Resistance; Thymidine kinase

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; DNA POLYMERASE; THYMIDINE KINASE; VIRUS ENZYME;

CODON; DNA HYBRIDIZATION; ENZYME ANALYSIS; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; PHENOTYPE; PREVALENCE; REVIEW; VIRUS CULTURE; VIRUS REPLICATION; VIRUS STRAIN;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0032996914     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Elion GB. Acyclovir : discovery, mechanism of action and selectivity. J Med Virol 1993 (Suppl 1) : 2-6
2. Collins P, Ellis MN. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol 1993 (Suppl 1) . 58-66.
3. Nugier F, Colin JN, Aymard M, Langlois M. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates : report on a two-year sensitivity screening survey. J Med Virol 1992 ; 36 : 1-12.
4. Christophers J, Clayton J, Craske J, et al. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrobial Agents Chemother 1998 ; 42 : 868-72.
5. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS and the Acyclovir Study Group. Recurrence and resistance patterns of HSV following cessation of > 6 years of chronic suppression with acyclovir. J Infect Dis 1994 ; 169 : 1338-41
6. Straus SE, Takiff HE, Seidlin M, et al. Suppression of frequently recurring genital herpes : a placebo-controlled double-blind trial of oral acyclovir. N Engl J Med 1984 ; 310 : 1545-50.
7. Kost RG, Hill EL, Tigges M, Straus SE. Brief report : recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 1993 ; 329 : 1777-82.
8. Mouly F, Baccard M, Scieux C, et al. Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient. Dermatology 1995 ; 190 : 177.
9. Swetter SM, Hill EL, Kern ER, et al. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant thymidine kinase-deficient herpes simplex virus. J Infect Dis 1998 ; 177 : 543-50.
10. Englund JA, Zimmerman ME, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH. Herpes simplex virus resistant to acyclovir : a study in a tertiary care center. Ann Intern Med 1990 ; 112 : 416-22.
11. Collins P, Oliver NM. Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J Antimicrobial Chem 1986 ; 18 (SupplB) . 103-12.
12. Youle MM, Hawkins DA, Collins P, et al Acyclovir-resistant herpes in Aids treated with foscarnet. Lancet 1988 341-2.
13. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 1991 ; 325 : 551-5.
14. Boyd MR, Safrin S, Kern ER. Penciclovir : a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem Chemother 1993 ; 4 (Suppl 1) : 3-11.
15. Chiou HC, Kumura K, Hu A, Kerns KM, Coen DM. Penciclovir-resistance mutations in the herpes simplex virus DNA polymerase gene. Antiviral Chem Chemother 1995 ; 6 : 281-8.
16. Reusser P, Cordonnier C, Einsele H, et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrow Transpl 1996 ; 17 : 813-7.
17. Safrin S, Assaykeen T, Foolansbee S, Mills J. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 patients : preliminary data. J Infect Dis 1990 ; 161 : 1078-84.
18. Safrin S, Kemmerly S, Plotkin B, et al. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 1994 ; 169 : 193-6.
19. Snoeck R, Andrei G, Gerard M, et al. Succesfull treatment of progressive mucocutaneous infection due to acyclovir- and foscanet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl) cytosine (HPMPC) Clin Infect Dis 1994 ; 18 : 570-8.
20. Swierkosz EM, Scholl DR, Brown JL, Jollick JD, Gleaves CA. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrobial Agents Chemother 1987 ; 31 : 1465-9.
21. Langlois M, Allard JP, Nugier F, Aymard M. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J Biol Stand 1986 ; 14 : 201-11.
22. Safrin S, Phan L, Elbeik T. A comparative evaluation of three methods of antiviral susceptibility testing of clinical herpes simplex virus isolates. Clin Diagn Virol 1995 ; 4 : 81-91.
23. Burns WH, Saral R, Santos GW, et al. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy. Lancet 1982 : 421-3.
24. Nugier F, Collins P, Larder BA, Langlois M, Aymard M, Darby G. Herpes simplex virus isolates from an immunocompromised patient who failed to respond to acyclovir treatment express thymidine kinase with altered substrate specificity. Antiviral Chem Chemother 1991 ; 2 : 295-302.
25. Field HJ, Wilby P. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J Hyg 1978 ; 81 : 267-77.
26. Darby G, Field HJ, Salisbury SA Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir resistance. Nature 1981 ; 289 : 81-3.
27. Martin JL, Ellis MN, Keller PM, et al. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrobial Agents Chemother1985 ; 28 : 181-7.
28. Ooka T, Lenoir G, Daillie J. Characterization of an Epstein-Barr virus-induced DNA polymerase. J Virol 1979 ; 29 : 1-10.
29. Darby G, Larder BA, Inglis MM. Evidence that the «active centre » of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J Gen Virol 1986 ; 67 : 753-8.
30. Gaudreau A, Hill E, Balfour HJ, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 1998 ; 178 : 297-303.
31. Rechtin TM, Black ME, Mao F, Lewis ML, Drake RR. Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase. J Biol Chem 1995 ; 270 : 7055-60.
32. Hwang CBC, Horsburgh B, Pelosi E, Roberts S, Digard P, Coen DM. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci USA 1994 ; 91 : 5461-5.
33. Kit S, Sheppard M, Ichimura H, et al. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir. Antimicrobial Agents Chemother 1987 ; 31 : 1483-90.
34. Palu G, Gerna G, Bevilacqua F, Marcello A. A point mutation in the thymidine kinase gene is responsible for acyclovir resistance in herpes simplex virus type 2 sequential isolates. Virus Res 1992 ; 25 : 133-44.
35. Collins P, Larder BA, Oliver NM, Kemp S, Smith IW, Darby G. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol 1989 ; 70 : 375-82.
36. Sacks SL, Wanklin RJ, Reece DE, Hicks KA, Tyler KL, Coen DM. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity. Ann Intern Med 1989 ; 111 : 893-9.
37. Hwang CBC, Ruffner KL, Coen DM. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J Virol 1992 ; 66 : 1774-6.
38. Parris DS, Harrington JE. Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrobial Agents Chemother 1982 ; 22 : 71-7
39. 125I]iododeoxycytidine by cells infected with herpes simplex virus . a rapid screening test for resistance to acyclovir. J Infect Dis 1985 ; 152 : 1206-11.
40. Coen DM, Irmiere AF, Jacobson JG, Kerns KM. Low levels of herpes simplex virus thymidme-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology 1989 ; 168 : 221-31.
41. Larder BA, Kemp SD, Darby G. Related functional domains in virus DNA polymerases. EMBO J 1987 ; 6 : 169-75.